Ident. | Authors (with country if any) | Title |
---|
000039 (2021) |
Roland Duculan ; Deanna Jannat-Khah ; Bella Mehta ; Lisa A. Mandl ; Medha Barbhaiya ; Anne R. Bass ; Carol A. Mancuso | Variables Associated With Perceived Risk of Contracting SARS-CoV-2 Infection During the COVID-19 Pandemic Among Patients With Systemic Rheumatic Diseases. |
000188 (2021) |
Veronique Michaud [États-Unis, Canada] ; Pamela Dow [États-Unis] ; Sweilem B. Al Rihani [États-Unis] ; Malavika Deodhar [États-Unis] ; Meghan Arwood [États-Unis] ; Brian Cicali [États-Unis] ; Jacques Turgeon [États-Unis, Canada] | Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs. |
000498 (2021) |
Rupesh Agrawal [Singapour, Royaume-Uni] ; Ilaria Testi [Royaume-Uni] ; Cecilia S. Lee [États-Unis] ; Edmund Tsui [États-Unis] ; Marian Blazes [États-Unis] ; Jennifer E. Thorne [États-Unis] ; Annabelle A. Okada [Japon] ; Justine R. Smith [Australie] ; Peter J. Mccluskey [Australie] ; John H. Kempen [États-Unis, Éthiopie] ; Christoph Tappeiner [Suisse] ; Manisha Agarwal [Inde] ; Bahram Bodaghi [France] ; Quan Dong Nguyen [États-Unis] ; Vishali Gupta [Inde] ; Marc D. De Smet [Belgique] ; Manfred Zierhut [Allemagne] ; Carlos Pavesio [Royaume-Uni] | Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. |
000612 (2021) |
Jennifer Carron [Irlande (pays)] ; Zain Sharif [Irlande (pays)] ; Hafiz Hussein [Irlande (pays)] ; Mark Kennedy [Irlande (pays)] ; Brendan Mcadam [Irlande (pays)] ; Richard Sheahan [Irlande (pays)] | Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic. |
000654 (2021) |
Azita Hajhossein Talasaz [Iran] ; Hessam Kakavand [Iran] ; Benjamin Van Tassell [États-Unis] ; Maryam Aghakouchakzadeh [Iran] ; Parham Sadeghipour [Iran] ; Steven Dunn [États-Unis] ; Babak Geraiely [Iran] | Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective. |
000655 (2021) |
Pierre Jordaan [Suisse] ; Bérengère Dumotier [Suisse] ; Martin Traebert [Suisse] ; Paul E. Miller [États-Unis] ; Andre Ghetti [États-Unis] ; Laszlo Urban [États-Unis] ; Najah Abi-Gerges [États-Unis] | Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes. |
000674 (2021) |
Hussain Ahmed Raza [Pakistan] ; Javeria Tariq [Pakistan] ; Vikas Agarwal [Inde] ; Latika Gupta [Inde] | COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases. |
000770 (2021) |
François Lamontagne [Canada] ; Thomas Agoritsas [Suisse, Canada, Norvège] ; Reed Siemieniuk [Canada] ; Bram Rochwerg [Canada] ; Jessica Bartoszko [Canada] ; Lisa Askie [Suisse] ; Helen Macdonald [Royaume-Uni] ; Wagdy Amin [Égypte] ; Frederique Jacquerioz Bausch [Suisse] ; Erlina Burhan ; Maurizio Cecconi [Italie] ; Duncan Chanda [Zambie] ; Vu Quoc Dat [Viêt Nam] ; Bin Du [République populaire de Chine] ; Heike Geduld [Afrique du Sud] ; Patrick Gee [États-Unis] ; Harley Nerina [Australie] ; Madiha Hashimi [Pakistan] ; Beverley J. Hunt [Royaume-Uni] ; Sushil Kabra [Inde] ; Seema Kanda [Canada] ; Leticia Kawano-Dourado [Brésil] ; Yae-Jean Kim [Corée du Sud] ; Niranjan Kissoon [Canada] ; Arthur Kwizera [Ouganda] ; Yee-Sin Leo [Singapour] ; Imelda Mahaka [Zimbabwe] ; Hela Manai [Tunisie] ; Greta Mino [Équateur] ; Emmanuel Nsutebu ; Natalia Pshenichnaya [Russie] ; Nida Qadir [États-Unis] ; Shalini Sri Ranganathan [Sri Lanka] ; Saniya Sabzwari [Pakistan] ; Rohit Sarin [Inde] ; Michael Sharland [Royaume-Uni] ; Yinzhong Shen [République populaire de Chine] ; Joao Paulo Souza [Brésil] ; Miriam Stegemann [Allemagne] ; Sebastian Ugarte [Chili] ; Sridhar Venkatapuram [Royaume-Uni] ; Dubula Vuyiseka [Afrique du Sud] ; Jacobus Preller [Suisse] ; Romina Brignardello-Petersen [Canada] ; Elena Kum [Canada] ; Anila Qasim [Canada] ; Dena Zeraatkar [Canada] ; Andrew Owen [Royaume-Uni] ; Gordon Guyatt [Canada] ; Lyubov Lytvyn [Canada] ; Janet Diaz [Suisse] ; Per Olav Vandvik [Norvège] ; Michael Jacobs [Canada] | A living WHO guideline on drugs to prevent covid-19. |
000805 (2020) |
Naeem A. Alshoaibi [Arabie saoudite] ; Khadijah Maghrabi [Arabie saoudite] ; Haitham Alanazi [Arabie saoudite] ; Mousa Al Harbi [Arabie saoudite] ; Saleh Alghamdi [Arabie saoudite] | Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19. |
000821 (2020) |
Cosima Rughini [Roumanie] ; Lorena Dima ; Sorina Vasile [Roumanie] | Hydroxychloroquine and COVID-19: Lack of Efficacy and the Social Construction of Plausibility. |
000838 (2020) |
Seema Rani [Inde] ; Sandeep Grover [Inde] ; Aseem Mehra [Inde] ; Swapnajeet Sahoo [Inde] | Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients. |
000955 (2020) |
Giuseppe Di Pasquale ; Aldo P. Maggioni | [COVID-19 trials: surfing between expectations and illusions, looking forward to evidence]. |
000B29 (2020) |
Luis Ayerbe [Royaume-Uni] ; Carlos Risco [Espagne] ; Salma Ayis [Royaume-Uni] | The association between treatment with heparin and survival in patients with Covid-19. |
000B53 (2020) |
Karl A. Nath | The COVID-19 Pandemic and Mayo Clinic Proceedings. |
000B60 (2020) |
James P. Hummel ; Ilir Maraj ; Roy Taoutel ; Romy Chamoun ; Virginia K. Workman ; Lydia Tran ; Johny M. Abboud ; Claude Afif ; Salah Chouairi ; Alexander Delvecchio ; Christopher J. Howes ; Alan D. Enriquez ; Joseph G. Akar | Temporal Trends in Arrhythmogenicity Related to Treatment of COVID-19 Infection. |
000B89 (2020) |
S. Banerjee [Royaume-Uni] ; S. Sarkar [Inde] ; S N Bandyopadhyay [Inde] | Survey and analysis of knowledge, attitude and practice among otolaryngologists in a state in eastern India in relation to the coronavirus disease 2019 pandemic. |
000C48 (2020) |
Moussa Saleh [États-Unis] ; James Gabriels [États-Unis] ; David Chang [États-Unis] ; Joanna Fishbein [États-Unis] ; Michael Qiu [États-Unis] ; Stavros E. Mountantonakis [États-Unis] ; Laurence M. Epstein [États-Unis] | Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era. |
000C67 (2020) |
María Fernanda Zurita [Équateur] ; Adriana Iglesias Arreaga [Équateur] ; Adriana A. Luzuriaga Chavez [Équateur] ; Luis Zurita [Équateur] | SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus. |
000C76 (2020) |
Silvia Rizzi [Danemark] ; Maarten J. Wensink [Danemark] ; Rune Lindahl-Jacobsen [Danemark] ; Lu Tian [États-Unis] ; Ying Lu [États-Unis] ; Michael L. Eisenberg [États-Unis] | Risk of pre-term births and major birth defects resulting from paternal intake of COVID-19 medications prior to conception. |
000C80 (2020) |
Nicholas J. Mercuro [États-Unis] ; Christina F. Yen [États-Unis] ; David J. Shim [États-Unis] ; Timothy R. Maher [États-Unis] ; Christopher M. Mccoy [États-Unis] ; Peter J. Zimetbaum [États-Unis] ; Howard S. Gold [États-Unis] | Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). |
000D56 (2020) |
Enrique Asensio [Mexique] ; Rafael Acunzo [Argentine] ; William Uribe [Colombie] ; Eduardo B. Saad [Brésil] ; Luis C. Sáenz [Colombie] | Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence. |